Sustainability & Climate

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

The organic retailer's third Wyoming store will create jobs with competitive pay and shake up the local grocery market when it opens this spring.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

With strong growth and key acquisitions, Haemonetics' CEO will lay out the company's vision for 2026 at a high-stakes investor conference.

Amidst a market downturn, CNH brings in leaders from Rivian and Nikola to spearhead its ambitious transformation in autonomy, AI, and global operations.

Aeromexico repeats as the world's most on-time airline, while Qatar Airways earns top honors for operational excellence in Cirium's 2025 rankings.

Ittefaq Salt secures nearly 1,800 acres for Himalayan salt mining to meet soaring global demand, but the expansion puts a spotlight on ethical promises.

Viomi Technology's $20M share repurchase program underscores faith in its 'Global Water' strategy, even as its stock faces a volatile market.

Cambodia's landmark decision to recognize Cambridge AS/A Levels creates new university pathways for students and sets a bold precedent for Southeast Asia.

Samsung Bioepis is now directly selling its Lucentis biosimilar in Europe, a move set to increase competition and improve access to vital eye disease treatments.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

A fatal head-on train collision near Machu Picchu leaves one dead and dozens injured, triggering a massive tourist rescue operation by Peruvian authorities.

South Korea's KLMBio is accelerating its global push with major investments in production and new products to capture the booming regenerative medicine market.

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

World No.1 table tennis star Sun Yingsha joins La Roche-Posay in a strategic play for Gen-Z hearts and the massive Asian beauty market.

A new white paper alleges many botanical supplements lack active ingredients. Is the industry ready for a scientific overhaul to prove what's in the bottle?

Insurtech firm PolicyStreet launches its largest promo yet, offering deep discounts and flexible payments to challenge traditional insurers in Malaysia.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.